PORTENT - POCTRN
Our centers
Center for Point of Care Technologies for Nutrition, Infection, and Cancer in Global Health at Cornell University
Focus: To support development, deployment, clinical validation, and commercialization of point-of-care technologies for nutrition, infection and cancer for global health in locations where access to better diagnostics can have the largest worldwide impact. We focus on technologies that address the primary needs of the most vulnerable in the US and internationally.
PORTENT is focused on supporting development, deployment, clinical validation, and commercialization of point-of-care technologies for nutrition, infection and cancer for global health in locations where access to better diagnostics can have the largest worldwide impact. They focus on technologies that address the primary needs of the most vulnerable in the US and internationally.
RADx: Rapid Acceleration of Diagnostics
In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADx®) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.
In the News
NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests
The need for new test verification and regulatory support for innovative diagnostics
NIH-funded screening study builds case for frequent COVID-19 antigen testing
RADx partnerships speed new COVID testing
Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort
RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)
COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative
The National Strategy From the COVID-19 Response and Pandemic Preparedness